Question Bank › Scarcity premium: the thing the company sells is

Scarcity premium: the thing the company sells is becoming harder to get, and management is letting the…

Scarcity premium: the thing the company sells is becoming harder to get, and management is letting the shortage do the s

Calls Tested
484
Answered YES
12
Hit Rate
2.5%
rare by design

Sabra Health Care REIT, Inc. (SBRA) — this company's answers

NO on the Q1 2023 call 2023-05-04 B
The model's full reasoning — Q1 2023 call → NOWe need to determine if management conveys that what the company sells is becoming harder for buyers to obtain, and that management is allowing that tightening to work in its favor. The company is a healthcare REIT, so it sells/leases properties, provides capital, etc. The question asks about "what the company sells" becoming harder for buyers to obtain. That could be properties for sale/lease, or investment opportunities. But the context: "availability of the company's own product, service, capacity, slots, units, or expertise is tightening relative to what buyers want" and management is letting that work in its favor. In the transcript, management discusses investment activity being light, competitive landscape, pricing uncertainty. They talk about not finding opportunities. They mention that they are seeing flow of assets but few interesting. They are focusing on preferred equity or higher yield. They are not seeing opportunities at full pricing. They are waiting for price discovery. They are being selective. But is that about their own product being scarce? Actually, they are a buyer of assets, not a seller. They are a REIT that acquires properties. So "what the company sells" is not really a product; they lease properties. But the question is about the company's own product/service becoming harder for buyers to obtain. For a REIT, they provide capital and lease space. Are they saying that their capital or properties are in high demand and they are being selective? They mention they are being selective about investments, but that's about them buying, not selling. They also mention they have ample liquidity and don't need to access capital markets. They are not selling anything scarce. The question might be interpreted as: Is the company's own offering (e.g., its properties for lease) becoming harder for tenants to obtain? But the transcript doesn't discuss that. They discuss occupancy recovery, but that's about their properties being filled, not about scarcity. They are trying to fill properties, not rationing them. Management talks about labor shortages, but that's a cost, not their product. They talk about investment activity being light, but that's about them buying assets, not selling. Thus, the answer is NO. They are not conveying that their own product is becoming harder for buyers to obtain. They are not letting scarcity work in their favor.

← Back to the full SBRA analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management convey that WHAT THE COMPANY SELLS IS BECOMING HARDER FOR BUYERS TO OBTAIN — that availability of the company's own product, service, capacity, slots, units, or expertise is tightening relative to what buyers want — AND that management is allowing that tightening to work in the company's favor, rather than racing to eliminate it? Answer YES when management's own words convey, in whatever form fits the business, ONE coherent situation as a present-tense reality: buyers who want what the company offers are finding it less available than before — longer waits, limited availability, output spoken for ahead of time, access that must be secured rather than assumed — and management describes responding to that scarcity from a position of choice: holding or raising price, being selective about which business to take, letting customers wait rather than over-expanding, or otherwise letting the shortage improve the terms on which the company does business. The scarcity may arise from any direction — the company's own deliberate restraint, industry capacity limits, slow-to-add supply, or demand simply outrunning what exists — and the form may vary widely across industries. What matters is that management presents the tightening as real and current, and treats it as something that strengthens the company's hand rather than as a problem to be urgently fixed. Answer NO if the company is comfortably supplying everything asked of it, or is chiefly working to stimulate, win, or defend demand. NO if the shortage described is of things the company BUYS — components, materials, freight, labor — that constrain its own shipments, without buyers competing for the company's own scarce output. NO if management describes the tightness purely as a problem it is urgently fixing, with no sense that it is improving the company's pricing, selectivity, or terms. NO if the scarcity is only anticipated for the future, or is presented as a brief disruption already resolved. NO if management merely reports strong demand or a good quarter without any sense that availability is tightening relative to demand. NO if the idea appears only in an analyst's question that management does not itself affirm. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
PRA ProAssurance Corporation Q1 2024 2024-05-11 D
AES The AES Corporation Q1 2024 2024-05-03 C+
PDS Precision Drilling Corporation Q1 2024 2024-04-25 B
LEGH Legacy Housing Corporation Q4 2023 2024-03-18 C
ALL The Allstate Corporation Q3 2023 2023-11-02 C+
DAL Delta Air Lines, Inc. Q2 2023 2023-07-13 A
UAL United Airlines Holdings, Inc. Q4 2022 2023-01-18 B
STM STMicroelectronics NV Q3 2018 2018-10-24 C+
ESS Essex Property Trust, Inc. Q2 2018 2018-08-03 B+
IRT Independence Realty Trust, Inc. Q2 2018 2018-08-02 B
RACE Ferrari N.V. Q3 2017 2017-11-02 C+
HPP Hudson Pacific Properties, Inc. Q4 2015 2016-02-25 C

How the model reasoned

LEGH · Q4 2023 → YESThe question is: Does management convey that WHAT THE COMPANY SELLS IS BECOMING HARDER FOR BUYERS TO OBTAIN — availability tightening — AND that management is allowing that tightening to work in the c...YES The transcript shows management explicitly holding production levels steady to build backlog rather than ramping output, while continuing to hold pricing levels. Duncan Bates states: “We have held pricing levels and held production levels as we continue to build a backlog across the manufacturing plants” and later “we decided, hey, let's keep production where it is and keep building the backlog.
STM · Q3 2018 → YESThe question is: Does management convey that WHAT THE COMPANY SELLS IS BECOMING HARDER FOR BUYERS TO OBTAIN — availability tightening — AND that management is allowing that tightening to work in the c...YES The transcript shows management describing current shortages and a "stretched supply chain" for their own products (especially Automotive and Power Discrete), with backlogs confirming demand outrunning availability. They explicitly note pricing upside from the fractured supply situation in Power and treat the tightness as a positive dynamic rather than an urgent problem to fix.
ALL · Q3 2023 → YESThe question is: Does management convey that WHAT THE COMPANY SELLS IS BECOMING HARDER FOR BUYERS TO OBTAIN — availability tightening — AND that management is allowing that tightening to work in the c...YES The transcript shows management explicitly restricting new business growth in unprofitable states (California, New York, New Jersey down 75% in new applications) and describing this as part of the profit improvement plan that is working in their favor by improving margins and allowing selective removal of restrictions only where target returns are achieved.

More from the question bank

Proof-point cadenceSomeone else already paid for the growthCorrecting the record with current factsLocus of control flipAhead of their own clockBetting on one customer's rampAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.